Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorCase Comprehensive Cancer Center

About this trial

This study is designed to investigate a novel approach to offer more ESRD participants the benefits associated with renal transplantation by increasing the supply of available allografts

Eligibility criteria

Qualifiers

Adults > 50 years

Willing and able to understand and sign informed consent

Must have high-quality pre-operative cross-sectional imaging (CT or MRI) to determine tumor characteristics and perform parenchymal volume analysis for split renal function

Patient who is a candidate for partial nephrectomy for cT1a mass who understands that partial nephrectomy is standard of care for such mass but wishes to be an altruistic kidney donor (primary incentive is altruism) via radical nephrectomy with loss of the entire kidney.

Disqualifiers

Known familial RCC syndrome

Preoperative GFR < 80 ml/min/1.73 m2

Proteinuria on urine dipstick or urinalysis (≥1+ considered positive)

Predicted new baseline GFR (NBGFR) following radical nephrectomy would be < 45

Trial design

Treatments tested in this trial

  • Donor Radical and Partial Nephrectomy
  • Kidney Transplantation
  • Laparoscopic Radical Nephrectomy

Treatment groups

5 Participants
are divided into 1 treatment group